Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external video platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name Youtube
Purpose External media

Clinical Trial Office

The DKFZ Clinical Trial Office (CTO) was founded in April 2018 to generate a strategic portfolio of clinical trials and data by enabling the performance of high-quality clinical trials under formal sponsorship of DKFZ. The CTO's main tasks are the establishment and implementation of structures and processes to ensure DKFZ's sponsor oversight in the start-up and conduction phase of clinical drug trials. In addition, the CTO is responsible for the scientific and administrative framework needed to support clinical research at DKFZ.

CTO advises scientists during the start-up phase of a clinical drug trial and coordinates the application for DKFZ's sponsorship. After a formal application for sponsorship, the CTO will initiate an internal review process and advise the management board in its decision to accept the sponsorship for a given clinical drug trial. During the preparation and conduct of a clinical trial, the CTO acts as the prime contact person for sponsor issues and oversees sponsor oversight activities.

Contact:
cto@dkfz.de

Dr. Julia Ritzerfeld (Head)
Tel: 06221-42 1678
j.ritzerfeld@dkfz.de

to top
powered by webEdition CMS